Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business

Publisert: 31.10.2024

Navamedic ASA: Invitation to 2024 3rd quarter presentation

Publisert: 28.10.2024

Navamedic wins joint Nordic antibiotics tender

Publisert: 07.10.2024

Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease

Publisert: 12.09.2024

Navamedic ASA – Mandatory notification of trade by primary insider

Publisert: 09.09.2024

NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS

Publisert: 09.09.2024